AI Startup Sonio Nabs €5M To Improve Prenatal Care

June 29, 2022 | 2 minutes read

Paris-based startup Sonio nets funding of 5M for its AI software associated to improve the prenatal care and treatment.

Putting artificial intelligence into prenatal care, the French startup Sonio has secured funding of €5 million . This fresh injection of investment comes from Elaia which also led the round alongside neRagtime and Bpifrance.

The startup’s pioneering technology helps practitioners during prenatal ultrasounds to optimize diagnosis and treatment. Their inherent mission is to empower fetal medicine professionals to secure pregnancy care. As its unique AI software provides prenatal medicine practitioners with all types of medical, imaging, genetic and environmental data to optimize prenatal screening and diagnosis- which is a game changer for the sector.  It is of no doubt that AI in healthcare is truly  been a game changer  as it allows medical practitioners to detect future ailments of patients by the analysis of data.

Founded in 2020, by Cécile Brosset, Dagmar Nuber, Rémi Besson, Stéphanie Allassonnière, Erwan Le Pennec, Yves Ville, Julien Stirnemann, Emmanuel Spaggiari,David Amouyal, Deepak Prakash- has holistic approach to improve the medical outcomes.

Already serving 150 healthcare professionals in Europe, the solution is  fully equipped to assist the most experienced medical practitioners.

The AI startup has also secured several partnerships with the likes of Samsung France (ultrasound manufacturer), as well as private clinics such as PointGyn (OneClinic) in France and GynEcho in Canada.  Sonio leverages 5 year of R&D and clinical development at Ecole polytechnique, the Prairie Institute and Necker Hospital in Paris.

Moving forward, Sonio wants to continue its mission to bring a positive impact to the medical world. However the per se mentioned investment will help the team to add embedded image recognition into the Sonio platform. Also adding a boost to its plan of entering the US and getting FDA clearance. It also has plans to  revamp its sales process in Europe.

Cécile Brosset, Chief Executive Officer and Co-Founder of Sonio, said:

“Sonio addresses very important issues for both pregnant women and fetal medicine practitioners with a unique combination of artificial intelligence and clinical expertise. This new round of financing will allow us to recruit the talents we need both in software development and sales, and bring to the market our full suite of products.”